Analyst are loading up their customer base on shares of SUPG. Next year financial picture could easily be:
12.2M Nipent deferment 14.0M Nipent acceleration 15.0M Dacogen royalities could be 20.M+ 10.0M Nipent EU deal...estimated total deal at 25M 15.0M Dacogen Milestone EU approval MDS...could be 23.75M 6.0M Interest on 74M in cash 72.2M Total
32.0M Expenses 40.0M Profit or .71 EPS for the year!!!!!!!!!!
Do the math!!!!!! SUPG could have 110M in cash on 12/31/07
Billy, you estimated last quarter with fabulous numbers. What happened to last quarter and why has supg dropped from $5.78 to $5.04 ? I have many shares of supg however those bashers do point out how you keep on pumpimg supg regardless of actually numbers. Can you tell us the truth instead of pumping up supg.
BINGO....and if SUPG partners up on their pipeline you could see expenses (cash burn) decrease and cash position greatly increase. Watch for Orethecin/pipeline spin out. I believe combining one of SUPG pipeline and Orethecin will be announced soon. This stock could be flirting with $20 late next year....unless MGI wakes up and smells the coffee.